Immunomodulation by orally administered β-glucan in mice
- 1 January 1989
- journal article
- Published by Elsevier BV in International Journal of Immunopharmacology
- Vol. 11 (7), 761-769
- https://doi.org/10.1016/0192-0561(89)90130-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The effects of a highly branched .BETA.-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.Journal of Pharmacobio-Dynamics, 1988
- Two different conformations of the antitumour β-d-glucan produced by Sclerotinia sclerotiorum IFO 9395Carbohydrate Research, 1987
- Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory T-cell networks in the mucosal immune systemNature, 1986
- Structure and antitumor activity of a .BETA.-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Update on the immunomodulating activities of glucansSpringer Seminars in Immunopathology, 1985
- T-cell mediated vascular dilatation and hemorrhage induced by antitumour polysaccharidesInternational Journal of Immunopharmacology, 1984
- Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.The Journal of Experimental Medicine, 1984
- Oral administration of the methanol extraction residue of BCG (MER/BCG): A phase I study in non-oat cell lung cancer patientsInternational Journal of Immunopharmacology, 1983
- Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria.The Journal of Experimental Medicine, 1982
- Intestinal M Cells: A Pathway for Entry of Reovirus into the HostScience, 1981